-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52

Benzinga·10/29/2026 19:23:16
語音播報
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.